Moves to release more data from clinical trials could provide unprecedented opportunities to understand disease biology and drug effects.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Changing R&D models in research-based pharmaceutical companies
Journal of Translational Medicine Open Access 27 April 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Harrison, C. GlaxoSmithKline opens the door on clinical data sharing. Nat Rev Drug Discov 11, 891–892 (2012). https://doi.org/10.1038/nrd3907
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd3907
This article is cited by
-
Changing R&D models in research-based pharmaceutical companies
Journal of Translational Medicine (2016)